SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-052349
Filing Date
2022-04-28
Accepted
2022-04-28 16:45:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm223497d2_defa14a.htm DEFA14A 9291
2 GRAPHIC tm223497d2_defa14aimg001.jpg GRAPHIC 154184
3 GRAPHIC tm223497d2_defa14aimg002.jpg GRAPHIC 139062
  Complete submission text file 0001104659-22-052349.txt   414406
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38492 | Film No.: 22867468
SIC: 2834 Pharmaceutical Preparations